Načítá se...
TSHR as a therapeutic target in Graves’ disease
Graves’ disease (GD) and its extrathyroidal manifestations such as thyroid-associated ophthalmopathy (TAO) are thought to result from abnormal activities of pathogenic antibodies mediated through the thyrotropin receptor (TSHR). At the core of GD is the loss of immune tolerance to TSHR and the gener...
Uloženo v:
| Vydáno v: | Expert Opin Ther Targets |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5718165/ https://ncbi.nlm.nih.gov/pubmed/28127991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2017.1288215 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|